Tenaya Therapeutics grants CFO stock options for 1.65 million shares at $0.84 each
TNYA•Stock option grants to new CFO and employees
Tenaya Therapeutics granted stock options for 1,650,000 shares to newly appointed CFO Eric Hyllengren.
Two new non-executive employees also received options covering 187,200 shares in aggregate.
The options were priced at $0.84 per share, matching the July 13, 2026 close. They have a ten-year term and vest over four years, with 25% vesting after one year and the remainder vesting monthly thereafter.
The awards were issued under the 2024 Inducement Equity Incentive Plan.
